Group One Trading
ENZN

Group One Trading’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Group One Trading’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,800
Closed -$2K – 5375
2015
Q4 		$2K Sell
2,800
-5,500
-66% -$4.36K ﹤0.01% 4571
2015
Q3 		$8K Sell
8,300
-9,900
-54% -$12.2K ﹤0.01% 4395
2015
Q2 		$22K Buy
18,200
+12,200
+203% +$15.5K ﹤0.01% 4000
2015
Q1 		$6K Buy
+6,000
New +$6.21K ﹤0.01% 4337
2014
Q4 		– Sell
-3,400
Closed -$4K – 5654
2014
Q3 		$4K Hold
3,400
– – ﹤0.01% 4821
2014
Q2 		$4K Buy
+3,400
New +$3.24K ﹤0.01% 4874
2014
Q1 		– Sell
-1,100
Closed -$1K – 5882
2013
Q4 		$1K Hold
1,100
– – ﹤0.01% 5155
2013
Q3 		$2K Hold
1,100
– – ﹤0.01% 4991
2013
Q2 		$2K Buy
+1,100
New +$3.22K ﹤0.01% 4929

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Group One Trading's ENZN Position: Q1 2016 in Review

Group One Trading sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q1 2016, closing a stake of 798 shares — an estimated $1K sold.

Group One Trading first reported a position in ENZN in Q2 2013 and held it in 10 quarters. The position peaked at $22K in Q3 2014. 40 funds tracked by Wall St. Rank hold ENZN as of Q1 2016.

  • Group One Trading reported no remaining ENZON PHARMACEUTICALS INC position as of Q1 2016 after selling out during the quarter.
  • Group One Trading sold 798 ENZON PHARMACEUTICALS INC shares in Q1 2016, an estimated $1K.
  • Group One Trading first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 10 quarters.
  • Group One Trading's ENZON PHARMACEUTICALS INC position peaked at $22K in Q3 2014.
  • 40 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q1 2016.

Based on Group One Trading's 13F filing for Q1 2016, filed 12 May 2016.